GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Construction In Progress

Aprinoia Therapeutics (Aprinoia Therapeutics) Construction In Progress : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Construction In Progress?

Aprinoia Therapeutics's quarterly construction in progress increased from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($0.35 Mil) but then declined from Dec. 2022 ($0.35 Mil) to Jun. 2023 ($0.00 Mil).

Aprinoia Therapeutics's annual construction in progress increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.27 Mil) and increased from Dec. 2021 ($0.27 Mil) to Dec. 2022 ($0.35 Mil).

Aprinoia Therapeutics Construction In Progress Historical Data

The historical data trend for Aprinoia Therapeutics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Construction In Progress Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22
Construction In Progress
0.27 0.35

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23
Construction In Progress 0.27 - 0.35 -

Aprinoia Therapeutics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Construction In Progress
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines